Skip to main
NHI

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors is a real estate investment trust focused on senior housing and medical facilities. The company's diversified portfolio and strong financials, including low net debt/EBITDA, suggest it is well-positioned for growth and resilience in the current market. The recent sale of its assisted living facilities improves the company's operator concentration and reduces potential conflicts of interest. Risks include potential lower-than-expected NHC rent reset and weaker deferred rent collections, but the company has a solid track record and potential for upside with its focus on RIDEA and strategic acquisitions.

Bears say

National Health Investors is facing headwinds due to its recent portfolio sale and subsequent decrease in portfolio diversity, leading to a decline in normalized FFO estimates as well as a decrease in projected returns for investors. The company's reliance on senior housing and SHOP ventures also raises concerns given the somewhat disappointing performance of its existing SHOP portfolio. Furthermore, while the sale does provide NHI with a significant amount of dry powder, the company's ability to prudently deploy these funds will now be heavily scrutinized by investors.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Jun 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $84.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $84.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.